Clinical trial
Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest
NCT02542306 is registered in ClinicalTrials.gov with Hongjia Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest
- Lead sponsor
- Hongjia Zhang
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- August 31, 2016
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
proximal aortic dissection